Understanding the neural mechanisms of lisdexamfetamine dimesylate (LDX) pharmacotherapy in Binge Eating Disorder (BED): a study protocol

BACKGROUND: The efficacy and safety of Lisdexamfetamine dimesylate (LDX) in the treatment of moderate to severe binge eating disorder (BED) has been demonstrated in multiple randomised clinical trials. Despite this, little is known about how LDX acts to improve binge eating symptoms. This study aims...

Descripción completa

Detalles Bibliográficos
Autores principales: Griffiths, Kristi R., Yang, Jenny, Touyz, Stephen W., Hay, Phillipa J., Clarke, Simon D., Korgaonkar, Mayuresh S., Gomes, Linette, Anderson, Gail, Foster, Sheryl, Kohn, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621979/
https://www.ncbi.nlm.nih.gov/pubmed/31333843
http://dx.doi.org/10.1186/s40337-019-0253-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6621979/
https://www.ncbi.nlm.nih.gov/pubmed/31333843
http://dx.doi.org/10.1186/s40337-019-0253-3

Ejemplares similares